BeyondSpring competitorsClear all

Omeros's top competitors include Otonomy and Jiangsu Hansoh Pharmaceutical Group.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Omeros
Omeros
Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Jiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.
Founding Date
Founding Date
1994
Founding Date
2008
Founding Date
1995
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
San Diego, US HQ
Locations
Lianyungang Shi, CN HQ
Employees
Employees
2777% increase
Employees
49
Employees
11,645
Valuation ($)
Valuation ($)
512.2 m
Valuation ($)
120.7 m
Valuation ($)
N/A
Twitter followers
Twitter followers
336
Twitter followers
208
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
276762
Alexa Website Rank
116688
Alexa Website Rank
N/A
Employee Rating
Employee Rating
3.5
Employee Rating
4.3
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$73.8m (FY, 2020)
Revenue (est.)
$273k (FY, 2020)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$902k (FY, 2020)
Cost of goods
$1.2m (FY, 2020)
Cost of goods
N/A
Gross profit
Gross profit
$72.9m (FY, 2020)
Gross profit
($915k) (FY, 2020)
Gross profit
N/A
Net income
Net income
($138.1m) (FY, 2020)
Net income
($44.7m) (FY, 2020)
Net income
N/A

Operating

Phase I Trials Products
Phase I Trials Products
2 (FY, 2020)
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
2 (FY, 2020)
Phase II Trials Products
2 (FY, 2016)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
3 (FY, 2020)
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 354.8m
Total funding raised
$ 153.4m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Otonomy
HQ
San Diego, US
Employees
49

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company
Jiangsu Hansoh Pharmaceutical Group
HQ
Lianyungang Shi, CN
Employees
11,645

Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.

View company